[Report] Proteomics Market Research TOC

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions And Scope of Study
Expression Proteomics
Functional Proteomics
Structural Proteomics

II. EXECUTIVE SUMMARY

1. Global Market Overview

Current Spotlight
Genesis of Proteomics
Tales From Times Gone By
Proteomics: A Critical Drug Discovery Tool
Factors Influencing the Market
Market Drivers
Factors Limiting Market Growth
Major Challenges
Proteomics Sample Preparation Market
Protein Chemistry and its Complexities
Integration of Data & Equipment
Data Validation - A Burning Issue
Standardization & Consistency- A Prime Concern

2. Industry Competition

Industry Participants
Proteomics Market Worldwide: CompetitiveLandscape
Proteomics Supplier Market
Challenges Ahead
Designing a Novel Business Model

3. Product and Technology Overview

Proteins, Proteome and Proteomics…!!!- What are They?
Proteomics - An Introduction
Significance of a Proteomicist
Components of Proteomics
Expression Proteomics
Functional Proteomics
Cell-map Proteomics
Structural Proteomics
Technologies and Proteomics
Proteomics and Genomics
Proteomics and Genomics: A Comparison
Protein Production Pathway: From Gene Expression toFunctional Protein with Controls
From Genomics to Proteomics
Functional Genomics and Proteomics
Push From Genomic Information
Standard Proteomics Approach
Sample Preparation- Step I
Protein Separation-Step II
Protein Visualization
Protein Expression Analysis-Step III
Protein Identification -Step IV
Data Storage and Processing-Step V

4. Overview of Proteomics Technologies

A Snapshot of Various Proteomics Tools
An Insight into Various Proteomics Technologies andtheir Application Areas
Protein Separation
Table 1: Worldwide Protein Separation Market(2003-2008P): Market Share of Leading Players-Applied Biosystems, Waters Corp., AmershamBiosciences, Agilent Technologies Inc., Bio-Rad/Micromass, Thermo Electron, and Others(Includes corresponding Graph/Chart)
2-Dimensional Gel Electrophoresis (2DGE)
Protein Characterization
Analysis of Protein Through Mass Spectrometry
MS and Proteins
Y2H, Yeast 2-Hybrid System
Protein Microarrays
Protein Array Tools and Associated Companies
Chip Technology
Microfluidic Applications
Role of Bioinformatics in Proteomics
Bioinformatics Applications and Tools in Proteomics
Emerging Proteomics Technologies
MudPIT
ICAT
Phage Display Technique
Advanced Proteomics Technologies: StructuralAnalysis Tools
X-ray Crystallography
Nuclear Magnetic Resonance (NMR)
In silico Modelling
Physicochemical Factors Constraining MetabolicFunctions

5. End-Use Application Areas

Proteomics in Drug and Diagnostic Discovery
Proteomics and Drug Discovery
Proteomic Approaches Gaining Prominence inCancer Drug Discovery
Leading Companies in Proteomics-Based DrugDiscovery
Future of Proteomics in Drug Discovery

6. New Product Solutions/Developments

Thermo Fisher Unveils the Latest LTQ XL massspectrometer
Dionex to Add SAX-1S and WCX-1S to Ion-exchangeProSwiftTM Monolith Columns Line
Genedata Introduces Genedata Expressionist® Pro 3.0
Biozentrum to Employ GeneBio’s Phenyx as PrimarySearch Engine
Shimadzu Biotech Unveils AXIMA-TOF2
Waters Corporation Unveils Latest Columns for PeptideAnalysis and Isolation
Applied Biosystems and MDS Sciex Unveil QSTAR®Elite LC/MS/MS System
Waters Corporation to Roll out Updated ProteinLynxGlobal SERVER™ Version
Syngene Unveils the Latest Integrated ProteomicsProducts
Sigma Unveils the Latest ProteoPrep 20 PlasmaImmunodepletion Kit
Sigma-Aldrich Introduces First Commercial ProteomicsStandard
Bruker Daltonics and Serva Electrophoresis Unveil ICPLTriplex kit
Agilent Unveils 3100 OFFGEL Fractionator
Agilent Technologies Unveils Multiple AffinityRemoval System 7
Bio-Rad Unveils Proteon XPR36 Protein InteractionArray System
Sigma-Aldrich Adds Panorama Human Kinase v1Array to Extend Panorama Protein Array Line
PerkinElmer Expands Proteomic Research Tools Offering
Waters Launches Advanced Version of ProteomicsResearch Software
Lumera to Develop New Protein Biochip inCollaboration with HMS
Agilent Launches Ion Trap Mass Spectrometer,LC/MSD Trap XCT Ultra…
Bruker Launches Novel Mass Spectrometer System,HCTultra…
Bruker Launches Novel Post-Translational ProteinTechnique
Kinexus Launches New Functional Proteomic Database
Applied Biosystems Launches Series of LiquidChromatography Systems
Pall Introduces Three Novel Protein Purification Kits…
Ciphergen Launches Nex-Gen ProteinChip System,Series 4000
Ciphergen Introduces Protein Software in Collaborationwith Salford
Bruker Launches New Proteomics RIMS
Invitrogen Launches High-Density Protein Microarray
Amersham Biosciences Introduces Improved 2-D Software…
Proteome Introduces Latest Version of ProteomicSoftware Solutions…
Proteome Systems Introduces Intelligent ElectrophoresisSolutions
Applied Biosystems Develops 4700 System
Biacore Launches Functional Proteomics System
Biacore Launches Software and Sensor Chips
Biacore Launches Procel™
Agilent Introduces Dual Loop Autosampler forHPLC Purification
Agilent Introduces New Methods for RNAi
Agilent Introduces Human 1B Oligo Microarray Kit
Agilent Introduces New Seperation System
Agilent Introduces Nano-flow LC System
Ciphergen Launches IDM Platform
Dionex Releases Monolithic Capillary Columns
Beckman Enhances the Product Line of ProteomeLab
Eprogen Develops New Protein Mapping Technology
ABI, Millipore and PerkinElmer Life SciencesDevelop an Automated Solution
Proteome Systems Unveils ProteomIQ™
Shimadzu Biotech Launches Axima-Qit™
Millipore and Proteome Systems Introduce AlbuminDeplete Kits
Applied Biosystems Groups Introduces New ProteomicsAnalyser
Thermo Finnigan Launches ProteomeX™
MDS Proteomics Augments Bioinformatics TechnologyPlatform
Proteome Systems Introduces ProteomIQ™
Invitrogen Unveils New Proteomics System
Varian Launches BioStandard to Validate DHPLCSystems
Applied Biosystems Introduces Cleavable ICAT™technology
Agilent Technologies Launches Nanoflow ProteomicsSolution
Cytomyx Launches New Proteomics Service
GPC Biotech and MorphoSys Develop New AntibodyCompound
Shimadzu to Launch SNP Analysis Service
Applied Biosystems Group Unveils New Software Tools
Myriad Genetics Discovers New Drug
20/20 GeneSystems Inc Unveils New Drug
Prolinx Adds Two New Products to Product Portfolio
Boston Probes Develops Novel CompoundLibrary Technique
Varian Launches New 700 MHz Spectrometer
Ciphergen Biosystems Inc. Launches New ProductPortfolio
Oxford Glycosciences PLC Receives Patent forProteomics
CRS Successfully Completes Customer AcceptanceProgramme
Partek Awards License to Large Scale Proteomics

7. Recent Industry Activity

Ecopia and Caprion to Merge to Form ThallionPharmaceuticals
BG Medicine and Applied Biosystems to Collaborate forBiomarker Discovery and Development
Bio-Rad Acquires Ciphergen’s Proteomics InstrumentBusiness
BioMachines Establishes New Proteomics Services Unit
GE Acquires Biacore
Fuji Film Acquires Minority Stake in Perseus
Cenix BioScience, Applied Biosystems, and Biotec ofthe Technische Universität Dresden Collaborate
GeneBio and Goodlett Enter into Collaboration
Genetix Group to Acquire Applied Imaging
Massively Parallel Technologies Signs a Deal withUniversity of Colorado
Rosetta Biosoftware and Sage-N Research Team Up toIntegrate Respective Elucidator andSorcerer Systems
Genospectra Plans Merger with Panomics
PerkinElmer Announces Acquisition of ProteomicsLabeling Technology…
ActivX Biosciences Extends Alliance with Pfizer…
Ciphergen Signs Collaborative Research Agreementwith Sanofi-Aventis
Invitrogen Acquires Zymed…
FALCO Signs a Collaborative Agreement with PPD
Invitrogen Acquires BioSource International…
Agilix and Protana Enters into a Licensing Agreement…
Invitrogen Pacts Marketing Agreement with AppliedBiosystems…
Waters Corp. Pacts a Technical Collaborationwith Matrix
Kyorin Acquires ActivX Biosciences…
Bruker Signs Marketing Agreement with ServaElectrophoresis…
PerkinElmer Enters into a Marketing Agreementwith NLD…
Pepscan Collaborates with Cytos Biotechnology….
BD Acquires Protein Separation Technology ofFFE Weber…
Invitrogen Acquires Caltag Laboratories…
Qiagen Acquires Major Assets of LumiCyte
LifeSpan BioSciences Inks Long-Term Agreementwith Pfizer
Dana-Farber Cancer Institute To Establish ProteomicsResearch Center
Bruker, University of Goettingen and PANATecs Signsan Development Agreement
NextGen Sciences Partners with Protagen
GeneBio Collaborates with Genedata…
Sage-N Research to Establish R&D Center in China
Sage-N Research Integrates Sorcerer™ Systemswith TPP analysis Platform of ISB
Agilent Introduces Whole Human Genome Microarray
Invitrogen Acquires Protometrix…
Nanogen Acquires SXP…
BioCrossroads Establishes INCAPS, ProteinCenter of Excellence
Ciphergen Acquires Remaining Stake in CiphergenBiosystems K.K.
Shimadzu Inks OEM Agreement with Nonlinear Dynamics
Whatman Acquires Schleicher & Schuell
GE Healthcare Acquires Amersham Plc
GeneProt Extends Collaborative Agreementwith Novartis
GeneProt Collaborates with Lundbeck to Conduct CNSProteomics Study

8. Industry Activity in the Recent Past

9. Focus on Select Key Players

Agilent Technologies, Inc. (USA)
Applied Biosystems (USA)
Bio-Rad Laboratories, Inc.
Dionex Corporation (USA)
GE Healthcare (United Kingdom)
Biacore Life Sciences
Invitrogen Corporation (USA)
PerkinElmer, Inc. (USA)
Proteome Systems Ltd. (Australia)
Shimadzu Biotech (Japan)
Thermo Fisher Scientific (USA)

10. Global Market Perspective

Table 2: World Recent Past, Current & Future Analysis forProteomics by Geographic Region - US, Canada, Japan,Europe and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years2003 through 2010 (Includes correspondingGraph/Chart)
Table 3: World Long-term Projections for Proteomics byGeographic Region - US, Canada, Japan, Europe and Rest ofWorld Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015(Includes corresponding Graph/Chart)
Table 4: World 7-Year Perspective for Proteomics byGeographic Region/Country - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe andRest of World Markets for Years 2003, 2006 and2010 (Includes corresponding Graph/Chart)
Table 5: World Recent Past, Current & Future Analysis forProteomics by Product Segment - Expression Proteomics,Functional Proteomics and Structural Proteomics MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2010(Includes corresponding Graph/Chart)
Table 6: World Long-term Projections for Proteomics byProduct Segment - Expression Proteomics, FunctionalProteomics and Structural Proteomics Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2011 through 2015 (Includes correspondingGraph/Chart)
Table 7: World 7-Year Perspective for Proteomicsby Product Segment - Percentage Breakdown ofDollar Sales for Expression Proteomics, FunctionalProteomics and Structural Proteomics Marketsfor Years 2003, 2006 and 2010 (Includescorresponding Graph/Chart)

11. Glossary of Terms

1-D, 2-D, 3-D
Atmospheric Pressure Ionisation
Electrophoresis
Functional Genomics
High-Throughput
Liquid Chromatography (LC)
Mass Spectrometry (MS)
Matrix-Assisted Laser Desorption Ionisation (MALDI)
Nuclear Magnetic Resonance
X-ray Diffraction
Yeast Two-Hybrid System
2D-PAGE (Two-dimensional PolyAcrylamideGel Electrophoresis)
TOF (Time of Flight)
Quadrupole
Q-TOF (Quadrupole Time of Flight)
ESI (Electrospray Ionisation)

III. MARKET

1. The United States

A. Market Analysis
- Proteomics Sample Preparation Market
- Table 8: US Proteomics Market (2004): Market Shareof Leading Players in Proteomics Sample PreparationMarkets -GE Healthcare, Agilent Technologies,,Millipore Corporation, Bio-Rad Laboratories, Inc.,Invitrogen Corp., Sigma-Aldrich Co and Others(Ranked by Breakdown of Revenues) (Includescorresponding Graph/Chart)
- Proteomics Arrays Markets
- Table 9: US Proteomics Market (2005): Market Shareof Leading Players in Proteomics Array Segment-Bio-Rad Laboratories, Invitrogen Corporation,and Others (Includes correspondingGraph/Chart)
- Product Launches/Developments
- Strategic Corporate Developments
- Focus on Select Players
- ActivX Biosciences, Inc.
- Adnexus
- Agilent Technologies Inc.
- Applied Biosystems
- Bio-Rad Laboratories, Inc.
- Bruker Daltonics, Inc.
- Caliper Life Sciences
- Dionex Corporation
- Genomic Solutions, Inc.
- Human Genome Sciences, Inc.
- Invitrogen Corporation
- Large Scale Biology Corp.
- Millipore Corp.
- PerkinElmer, Inc.
- Thermo Fisher Scientific
- Waters Corp.
- Xencor,Inc.
- Zyomyx, Inc.
B. Market Analytics
- Table 10: US Recent Past, Current & Future Analysisfor Proteomics Market Independently Analyzed withAnnual Sales in US$ Million for Years 2003 through2010 (Includes corresponding Graph/Chart)
- Table 11: US Long-term Projections for ProteomicsMarket Independently Analyzed with Annual Sales inUS$ Million for Years 2011 through 2015(Includes corresponding Graph/Chart)

2. Canada

A. Market Analysis
- Research Funding
- Table 12: Canadian Funding for Genomics andProteomics Research from Various Sectors-Ranked By % Share for Government, Public Sector,Private Sector, and International Entities(Includes corresponding Graph/Chart)
- Product Launches
- Strategic Corporate Developments
- Key Player
- Caprion Pharmaceuticals, Inc.
B. Market Analytics
- Table 13: Canadian Recent Past, Current & FutureAnalysis for Proteomics Market IndependentlyAnalyzed with Annual Sales in US$ Millionfor Years 2003 through 2010 (Includescorresponding Graph/Chart)
- Table 14: Canadian Long-term Projectionsfor Proteomics Market IndependentlyAnalyzed with Annual Sales in US$ Millionfor Years 2011 through 2015 (Includescorresponding Graph/Chart)

3. Japan

A. Market Analysis
- Product Launches
- Strategic Corporate Developments
- Shimadzu Biotech - A Key Player
B. Market Analytics
- Table 15: Japanese Recent Past, Current & FutureAnalysis for Proteomics Market IndependentlyAnalyzed with Annual Sales in US$ Millionfor Years 2003 through 2010 (Includescorresponding Graph/Chart)
- Table 16: JapaneseLong-term Projections for ProteomicsMarket Independently Analyzed with Annual Sales inUS$ Million for Years 2011 through 2015(Includes corresponding Graph/Chart)

4. Europe

A. Market Analysis
- Europe on the Fast Track
- Table 17: European Proteomics Market (2004):Percentage Breakdown of Deployment of ProteomicsTechnologies in End-Use Segment- Research andAcademia Institutions, Pharmaceutical Companiesand Clinical Laboratories (Includescorresponding Graph/Chart)
B. Market Analytics
- Table 18: European Recent Past, Current & FutureAnalysis for Proteomics by Geographic Region/Country-France, Germany, UK and Rest of Europe MarketsIndependently Analyzed with Annual Salesin US$ Million for Years 2003 through 2010(Includes corresponding Graph/Chart)
- Table 19: European Long-term Projections for Proteomicsby Geographic Region/Country- France, Germany, UK andRest of Europe Markets Independently Analyzed withAnnual Sales in US$ Million for Years 2011 through2015 (Includes corresponding Graph/Chart)
- Table 20: European 7-Year Perspective for Proteomics byGeographic Region/Country - Percentage Breakdown ofDollar Sales for France, Germany, UK and Rest of EuropeMarkets for Years 2003, 2006 and 2010 (Includescorresponding Graph/Chart)

4a. France

A. Market Analysis
- Key Player Review
- Hybrigenics SA
B. Market Analytics
- Table 21: French Recent Past, Current & Future Analysisfor Proteomics Market Independently Analyzed withAnnual Sales in US$ Million for Years 2003 through2010 (Includes corresponding Graph/Chart)
- Table 22: French Long-term Projections for ProteomicsMarket Independently Analyzed with Annual Sales inUS$ Million for Years 2011 through 2015(Includes corresponding Graph/Chart)

4b. Germany

A. Market Analysis
- Outlook
- Product Launch
- Strategic Corporate Developments
- Key Player
- Xerion Pharmaceuticals GmbH
B. Market Analytics
- Table 23: German Recent Past, Current & Future Analysisfor Proteomics Market Independently Analyzed withAnnual Sales in US$ Million fo Years 2003 through2010 (Includes corresponding Graph/Chart)
- Table 24: German Long-term Projections for ProteomicsMarket Independently Analyzed with Annual Sales inUS$ Million for Years 2011 through 2015 (Includescorresponding Graph/Chart)

4c. The United Kingdom

A. Market Analysis
- Current Trends in the UK Market forProteomics
- Highlights
- Product Launches
- Strategic Corporate Developments
- Key Player
- GE Healthcare
B. Market Analytics
- Table 25: United Kingdom Recent Past, Current & FutureAnalysis for Proteomics Market Independently Analyzedwith Annual Sales in US$ Million fo Years 2003through 2010 (Includes correspondingGraph/Chart)
- Table 26: United Kingdom Long-term Projections forProteomics Market Independently Analyzed with AnnualSales in US$ Million for Years 2011 through 2015(Includes corresponding Graph/Chart)

4d. Rest of Europe

A. Market Analysis
- Switzerland
- Portugal
- Strategic Corporate Developments
- Key Players
- Biacore Life Sciences
- Geneva Bioinformatics S.A. (Switzerland)
B. Market Analytics
- Table 27: Rest of Europe Recent Past, Current & FutureAnalysis for Proteomics Market Independently Analyzedwith Annual Sales in US$ Million for Years 2003through 2010 (Includes correspondingGraph/Chart)
- Table 28: Rest of Europe Long-term Projections forProteomics Market Independently Analyzed with AnnualSales in US$ Million for Years 2011 through 2015(Includes corresponding Graph/Chart)

5. Rest of World

A. Market Analysis
- Outlook
- Australia
- India
- Indian Scientific Research towards FunctionalGenomics and Proteomics
- Strategic Corporate Developments
- Key Player
- Proteome Systems Ltd. (Australia)
B. Market Analytics
- Table 29: Rest of World Recent Past, Current &Future Analysis for Proteomics Market IndependentlyAnalyzed with Annual Sales in US$ Million forYears 2003 through 2010 (Includescorresponding Graph/Chart)
- Table 30: Rest of World Long-term Projections forProteomics Market Independently Analyzed with AnnualSales in US$ Million for Years 2011 through 2015(Includes corresponding Graph/Chart)

IV. COMPETITION

1. 20/20 Genesystems, Inc. (USA)
2. Ace Biosciences (Denmark)
3. Active Motif (USA)
4. Activx Biosciences, Inc. (USA)
5. Adnexus Therapeutics, Inc. (USA)
6. Affinium Pharmaceuticals, Inc. (Canada)
7. Agilent Technologies, Inc. (USA)
- Table 31: Nine Months Sales Analysis:2006 Vs. 2005 (Nine Months Ended, July)(In US$ million)
- Table 32: Nine Months Sales Analysis by Segment:2006 Vs. 2005 (Nine Months Ended, July)(In US$ million)
- Table 33: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 34: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 35: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 36: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
8. Agilix Corporation (USA)
9. Alphagene, Inc. (USA)
10. Amaxa GmbH (Germany)
11. Ambit Biosciences Corporation(USA)
12. Amgen, Inc. (USA)
- Table 37: Annual Sales Analysis: 2004-2006(In US$ million)
- Table 38: Annual Sales Analysis by Segment:2006 Vs. 2005 (In US$ million)
- Table 39: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 40: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
13. Applied Biosystems (USA)
- Table 41: Annual Sales Analysis: 2004-2006(In US$ million)
- Table 42: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
- Table 43: Annual Sales Analysis by Segment:2006 Vs. 2005 (In US$ million)
- Table 44: Annual Sales Analysis by Product:2006 Vs. 2005 (In US$ million)
- Table 45: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
- Table 46: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 47: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 48: Annual Sales Analysis by Product:2005 Vs. 2004 (In US$ million)
- Table 49: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
14. Aspira Biosystems, Inc. (USA)
15. Asterand PLC (UK)
16. Astex Therapeutics (UK)
17. Athersys Inc. (USA)
18. Aurelium Biopharma, Inc. (Canada)
19. Axcell Biosciences Corporation (USA)
20. BD Diagnostics (USA)
21. Beckman Coulter, Inc. (USA)
- Table 50: Annual Sales Analysis: 2004-2006(In US$ million)
- Table 51: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
- Table 52: Annual Sales Analysis by Business Segment:2006 Vs. 2005 (In US$ million)
- Table 53: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
- Table 54: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 55: Annual Sales Analysis by Business Segment:2005 Vs. 2004 (In US$ million)
- Table 56: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
22. BG Medicine Inc. (USA)
23. Biacore International AB (Sweden)
- Table 57: First Quarter Sales Analysis:2006 Vs. 2005 (In SEK million)
- Table 58: Annual Sales Analysis: 2005 Vs. 2004(In SEK million)
24. Biocarta, Inc. (USA)
25. BioCrossroads (USA)
26. BioImagene, Inc. (USA)
27. BioMachines, Inc. (USA)
28. BioMérieux SA (France)
- Table 59: Nine Months Sales Analysis: 2006 Vs. 2005(Nine Months Ended, September) (In € million)
- Table 60: Annual Sales Analysis: 2005 Vs. 2004(In € million)
29. Bio-Rad Laboratories, Inc. (USA)
- Table 61: Annual Sales Analysis: 2006-2004(In US$ million)
- Table 62: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
- Table 63: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 64: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 65: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
30. Biotec of the Technische Universität Dresden (Germany)
31. Boehringer Ingelheim Pharmaceuticals, Inc. (USA)
32. Bruker Biosciences Corporation (USA)
- Table 66: Nine Months Sales Analysis:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 67: Nine Months Sales Analysis by Segment:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 68: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 69: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 70: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 71: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
- Bruker Daltonik GmbH (Germany)
- Bruker Daltonics, Inc. (USA)
33. Caliper Life Sciences, Inc. (USA)
- Table 72: Half Yearly Sales Analysis:2006 Vs. 2005 (H1) (In US$ million)
- Table 73: Half Yearly Sales Analysis by Quarter:2006 Vs. 2005 (H1) (In US$ million)
- Table 74: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 75: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 76: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
34. Cambridge Antibody Technology (UK)
35. Caprion Pharmaceuticals, Inc. (Canada)
36. Celera Genomics Group (USA)
- Table 77: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
37. Cellzome AG (Germany)
38. Cenix BioScience GmbH (Germany)
39. Cephalon, Inc. (USA)
- Table 78: First Quarter Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 79: First Quarter Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
- Table 80: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 81: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
40. Charles River Laboratories (USA)
- Table 82: First Quarter Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 83: First Quarter Sales Analysis by Segment:2006 Vs. 2005 (In US$ million)
- Table 84: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 85: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 86: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 87: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
41. Ciphergen Biosystems, Inc. (USA)
- Table 88: Nine Months Sales Analysis: 2006 Vs. 2005(Nine Months Ended, September) (In US$ million)
- Table 89: Nine Months Sales Analysis by Quarter:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 90: Nine Months Sales Analysis by Segment:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 91: Nine Months Sales Analysis by GeographicRegion: 2006 Vs. 2005 (Nine Months Ended,September) (In US$ million)
- Table 92: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 93: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 94: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 95: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
- Ciphergen Biosystems K.K (Japan)
42. Commonwealth Biotechnologies, Inc. (USA)
- Table 96: First Quarter Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 97: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
43. Compugen, Ltd. (Israel)
- Table 98: First Quarter Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 99: Annual Sales Analysis: 2005 Vs.2004(In US$ million)
44. Crucell NV (The Netherlands)
- Table 100: Annual Sales Analysis: 2006 Vs. 2005(In € million)
45. CuraGen Corporation (USA)
- Table 101: First Quarter Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 102: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 103: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 104: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 105: Annual Sales Analysis by Operation:2005 Vs. 2004 (In US$ million)
46. Cytomyx, LLC (USA)
47. Cytos Biotechnology AG (Switzerland)
- Table 106: First Quarter Sales Analysis:2006 Vs. 2005 (In CHF million)
48. Dana-Farber Cancer Institute (USA)
49. Digilab BioVisioN GmbH (Germany)
50. Dionex Corporation (USA)
- Table 107: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ million)
- Table 108: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
- Table 109: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
- Table 110: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
51. Dualsystems Biotech AG (Switzerland)
52. Dyax Corporation (USA)
- Table 111: First Quarter Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 112: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 113: Quarterly Sales Analysis:2005 Vs. 2004 (In US$ million)
53. Ecopia BioSciences Inc. (Canada)
- Table 114: Annual Sales Analysis: 2006 Vs. 2005(In Can$ thousands)
54. Eprogen (USA)
55. Eragen Biosciences, Inc. (USA)
56. Eurogentec SA (Belgium)
57. Falco Biosystems Ltd. (Japan)
- Table 115: Annual Sales Analysis: 2005 Vs. 2004(In ¥ million)
58. GE Healthcare (UK)
59. GE Health Care - Life Sciences (USA)
- GE Healthcare Bio-Sciences (UK)
- Biacore Life Sciences (Sweden)
60. Gene Therapy Systems, Inc. (USA)
61. Geneart GmbH (Germany)
62. Genedata AG (Switzerland)
- Genedata, Inc. (USA)
63. Geneprot (Switzerland)
64. Genetix Group PLC (UK)
- Table 116: Market Share by Geographic Region:2006 (% Breakdown of Value Sales)
- Table 117: Annual Sales Analysis: 2006 Vs. 2005(In £ million)
65. Genetix Ltd. (UK)
66. Geneva Bioinformatics SA (Switzerland)
67. Genomic Solutions, Inc. (USA)
68. Genomics Institute Of The Novartis ResearchFoundation (USA)
69. Genvec, Inc. (USA)
- Table 118: Nine Months Sales Analysis:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 119: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 120: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
70. GlaxoSmithKline PLC (UK)
- Table 121: Annual Sales Analysis: 2006 Vs. 2005(In £ million)
- Table 122: Annual Sales Analysis by Segment:2006 Vs. 2005 (In £ million)
- Table 123: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In £ million)
71. GPC Biotech AG (Germany)
- Table 124: First Quarter Sales Analysis:2006 Vs.2005 (In € million)
- Table 125: Annual Sales Analysis: 2005 Vs. 2004(In € million)
72. Gyros AB (Sweden)
73. H. Lundbeck AS (Denmark)
- Table 126: Annual Sales Analysis: 2005 Vs. 2004(In DKK billion)
- Table 127: Quarterly Annual Sales Analysis:2005 Vs. 2004 (In DKK billion)
- Table 128: Annual Sales Analysis by ProductSegment: 2005 Vs. 2004 (In DKK billion)
- Table 129: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In DKK billion)
74. Harvard Institute of Proteomics (USA)
75. Health Discovery Corporation (USA)
- Table 130: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ thousands)
- Table 131: Annual Sales Analysis: 2006 Vs. 2005(In US$ thousands)
76. HTS Biosystems, Inc. (USA)
77. Human Genome Sciences, Inc. (USA)
- Table 132: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
- Table 133: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
78. Hybrigenics SA (France)
79. llumina, Inc. (USA)
- Table 134: Market Share Analysis by Segment:2006 Vs. 2005 (% Breakdown of Value Sales)
- Table 135: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
- Table 136: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
- Table 137: Annual Sales Analysis by Segment:2006 Vs. 2005 (In US$ million)
- Table 138: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
80. Imgenex Corporation (USA)
81. Incyte Corporation (USA)
82. Inpharmatica Ltd. (UK)
83. Institute For Systems Biology (USA)
84. Interomex Biopharmaceuticals, Inc. (Canada)
85. Intrinsic Bioprobes, Inc. (USA)
86. Invitrogen Corporation (USA)
- Table 139: Annual Sales Analysis: 2004-2006(In US$ million)
- Table 140: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
- Table 141: Annual Sales Analysis by BusinessSegment: 2006 Vs. 2005 (In US$ million)
- Table 142: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 143: Annual Sales Analysis by BusinessSegment: 2005 Vs. 2004 (In US$ million)
87. Kinexus Bioinformatics Corporation (Canada)
88. Kratos Analytical, Inc. (USA)
89. Large Scale Biology Corporation (USA)
- Table 144: Half Yearly Sales Analysis:2005 Vs. 2004 (H1) (In US$ million)
90. LifeSpan Biosciences, Inc. (USA)
91. LigoCyte Pharmaceuticals, Inc. (USA)
92. LION Bioscience AG (Germany)
93. Lumera Corporation (USA)
- Table 145: First Quarter Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 146: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 147: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
94. Massively Parallel Technologies, Inc. (USA)
95. Matritech, Inc. (USA)
- Table 148: First Quarter Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 149: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
96. Matrix Science Ltd. (UK)
97. MDS, Inc. (Canada)
- Table 150: First Quarter Sales Analysis:2007 Vs. 2006 (In Can$ million)
- Table 151: First Quarter Sales Analysis bySegment: 2007 Vs. 2006 (In Can$ million)
- Table 152: Annual Sales Analysis: 2006 Vs. 2005(In Can$ million)
- Table 153: Quarterly Sales Analysis: 2006 Vs. 2005(In Can$ million)
- Table 154: Annual Sales Analysis by Segment:2006 Vs. 2005 (In Can$ million)
- Table 155: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In Can$ million)
- MDS Sciex (Canada)
- MDS Proteomics, Inc. (Canada)
98. Media Cybernetics, Inc. (USA)
99. MelTec GmbH (Germany)
100. Metabometrix® Ltd. (UK)
101. Millipore Corporation (USA)
- Table 156: Nine Months Sales Analysis:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 157: Nine Months Sales Analysis by Quarter:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 158: Nine Months Sales Analysis by Segment:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 159: Nine Months Sales Analysis by GeographicRegion: 2006 Vs. 2005 (Nine Months Ended,September) (In US$ million)
- Table 160: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 161: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 162: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 163: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
- Millipore SA (France)
102. Mitsubishi Pharma Corporation (Japan)
103. Mobious Genomics Ltd. (UK)
104. Monarch Lifesciences (USA)
105. Myriad Genetics, Inc. (USA)
- Table 164: Nine Months Sales Analysis:2006 Vs. 2005 (Nine Months Ended, March)(In US$ million)
- Table 165: Nine Months Sales Analysis by Quarter:2006 Vs. 2005 (Nine Months Ended, March)(In US$ million)
- Table 166: Nine Months Sales Analysis by Segment:2006 Vs. 2005 (Nine Months Ended, March)(In US$ million)
- Table 167: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 168: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 169: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
106. Nanogen, Inc. (USA)
- Table 170: Nine Months Sales Analysis:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 171: Nine Months Sales Analysis by Quarter:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 172: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 173: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
107. Neurolab (France)
108. NextGen Sciences Ltd. (UK)
109. Nonlinear Dynamics Ltd. (UK)
110. Novartis AG (Switzerland)
- Table 174: Nine Months Sales Analysis:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 175: Nine Months Sales Analysis by Quarter:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 176: Nine Months Sales Analysis by Segment:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 177: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 178: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 179: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
- Novartis India Ltd. (India)
111. Owl Separations Systems, Inc. (USA)
112. Oxford Biomedica PLC (UK)
113. Pall Corporation (USA)
- Table 180: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ million)
- Table 181: First Quarter Sales Analysis by BusinessSegment: 2007 Vs. 2006 (In US$ million)
- Table 182: First Quarter Sales Analysis byGeographic Region: 2007 Vs. 2006(In US$ million)
- Table 183: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
- Table 184: Quarterly Sales Analysis: 2006 Vs. 2005(In US$ million)
- Table 185: Annual Sales Analysis By BusinessSegment: 2006 Vs. 2005 (In US$ million)
- Table 186: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
114. PANATecs GmbH (Germany)
115. Panomics, Inc. (USA)
116. Pepscan Systems (The Netherlands)
117. PerkinElmer, Inc. (USA)
- Table 187: Nine Months Sales Analysis:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 188: Nine Months Sales Analysis by Quarter:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 189: Nine Months Sales Analysis by BusinessSegment: 2006 Vs. 2005 (Nine Months Ended,September) (In US$ million)
- Table 190: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 191: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 192: Annual Sales Analysis by BusinessSegment: 2005 Vs. 2004 (In US$ million)
- Table 193: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
- Perkin-Elmer Life And Analytical Sciences (USA)
118. Perseus Proteomics, Inc. (Japan)
119. Pfizer, Inc. (USA)
- Table 194: Half Yearly Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 195: Half Yearly Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
- Table 196: Half Yearly Sales Analysis by BusinessSegment: 2006 Vs. 2005 (In US$ million)
- Table 197: Half Yearly Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
- Table 198: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
120. Pharmaceutical Product Development, Inc. (USA)
- Table 199: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ million)
- Table 200: Annual Sales Analysis: 2006 Vs 2005(In € million)
121. Predix Pharmaceuticals Ltd. (Israel)
122. Procognia Ltd. (USA)
123. Prolexys Pharmaceuticals, Inc. (USA)
124. Promega Corporation (USA)
125. Protagen AG (Germany)
126. Protea Biosciences, Inc. (USA)
127. Protein Pathways, Inc. (USA)
128. Proteome Factory AG (Germany)
129. Proteome Sciences PLC (UK)
- Table 201: Half Yearly Sales Analysis:2006 Vs. 2005 (H1) (In £ thousands)
- Table 202: Annual Sales Analysis: 2005 Vs. 2004(In £ thousands)
130. Proteome Systems Ltd. (Australia)
131. Proteomic Research Services, Inc. (USA)
132. ProteomTech, Inc. (USA)
133. Protiveris, Inc. (USA)
134. Proxeon Biosystems A/S (Denmark)
135. Prozyme, Inc. (USA)
136. Purely Proteins Ltd. (UK)
137. Qiagen NV (The Netherlands)
- Table 203: Nine Months Sales Analysis:2006 Vs. 2005 (Nine Months Ended, September)(In US$ million)
- Table 204: Nine Months Sales Analysis by GeographicRegion: 2006 Vs. 2005 (Nine Months Ended,September) (In US$ million)
- Table 205: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 206: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
138. Questar Bioinformatics Ltd. (India)
139. R. Shadel, Inc. (USA)
140. Rigel Pharmaceuticals, Inc. (USA)
- Table 207: First Quarter Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 208: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 209: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
141. Rosetta Inpharmatics, Inc. (USA)
142. Sage-N Research, Inc. (USA)
143. Sanofi-Aventis (France)
- Table 210: Nine Months Sales Analysis: 2006 Vs. 2005(Nine Months Ended, September) (In € million)
- Table 211: Nine Months Sales Analysis by Quarter:2006 Vs. 2005 (Nine Months Ended, September)(In € million)
- Table 212: Annual Sales Analysis: 2005 Vs. 2004(In € million)
- Table 213: Annual Sales Analysis by Segment:2005 Vs. 2004 (In € million)
- Table 214: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In € million)
144. Sartorius AG (Germany)
- Table 215: Nine Months Sales Analysis:2006 Vs. 2005 (Nine Months Ended, September)(In € million)
- Table 216: Annual Sales Analysis: 2005 Vs. 2004(In € million)
145. Scottish Biomedical (UK)
146. Sequenom, Inc. (USA)
- Table 217: First Quarter Sales Analysis:2006 Vs. 2005 (In US$ million)
- Table 218: First Quarter Sales Analysis bySegment: 2006 Vs. 2005 (In US$ million)
- Table 219: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
147. Serenex (USA)
148. Serva Electrophoresis GmbH (Germany)
149. Shimadzu Biotech (Japan)
150. Sidec Technologies AB (Sweden)
151. Sigma-Aldrich Corporation (USA)
- Table 220: Annual Sales Analysis: 2004-2006(In US$ million)
- Table 221: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
- Table 222: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 223: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 224: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
152. SomaLogic, Inc. (USA)
153. Sosei Co., Ltd. (Japan)
- Table 225: Annual Sales Analysis: 2007 Vs. 2006(In ¥ million)
154. Syngene (USA)
155. Takeda San Diego, Inc. (USA)
156. Target Discovery, Inc. (USA)
157. Tecan Group AG (Switzerland)
158. Thallion Pharmaceuticals, Inc. (Canada)
159. Thermo Fisher Scientific, Inc. (USA)
- Table 226: Market Share Analysis by Segment:2006 Vs. 2005 (% Breakdown of Value Sales)
- Table 227: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ million)
- Table 228: First Quarter Sales Analysis by BusinessSegment: 2007 Vs. 2006 (In US$ million)
- Table 229: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
- Table 230: Quarterly Sales Analysis: 2006 Vs.2005(In US$ million)
- Table 231: Annual Sales Analysis by BusinessSegment: 2006 Vs. 2005 (In US$ million)
- Table 232: Annual Sales Analysis by GeographicRegion: 2006 Vs 2005 (In US$ million)
- Thermo Finnigan (USA)
160. TopLab GmbH (Germany)
161. University of Washington - Goodlett Laboratory (USA)
162. Valentis, Inc. (USA)
- Table 233: Half Yearly Sales Analysis:2007 Vs. 2006 (H1) (In US$ million)
- Table 234: Annual Sales Analysis: 2004-2006(In US$ million)
- Table 235: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
- Table 236: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
163. Varian, Inc. (USA)
- Table 237: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ million)
- Table 238: First Quarter Sales Analysis by Segment:2007 Vs. 2006 (In US$ million)
- Table 239: Annual Sales Analysis: 2004-2006(In US$ million)
- Table 240: Annual Sales Analysis by Segment:2006 Vs. 2005 (In US$ million)
- Table 241: Annual Sales Analysis by Segment:2005 Vs. 2004 (In US$ million)
- Table 242: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
164. VBC-Genomics Bioscience Research GmbH (Austria)
165. Waters Corporation (USA)
- Table 243: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
- Table 244: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
- Table 245: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
166. Whatman PLC (UK)
- Table 246: Half Yearly Sales Analysis:2006 Vs. 2005 (H1) (In £ million)
- Table 247: Half Yearly Sales Analysis by Segment:2006 Vs. 2005 (H1) (In £ million)
- Table 248: Half Yearly Sales Analysis by GeographicRegion: 2006 Vs. 2005 (H1) (In £ million)
- Table 249: Annual Sales Analysis: 2005 Vs. 2004(In £ million)
- Table 250: Annual Sales Analysis by Segment:2005 Vs. 2004 (In £ million)
- Table 251: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In £ million)
167. Wyeth Biopharma (USA)
168. Xencor, Inc. (USA)
169. Xerion Pharmaceuticals GmbH (Germany)
170. Zyomyx, Inc. (USA)